Correction: Integrative network biology analysis identifies miR-508-3p as the determinant for the mesenchymal identity and a strong prognostic biomarker of ovarian cancer

Abstract

An amendment to this paper has been published and can be accessed via a link at the top of the paper.

Fig. S7

a Transwell chamber analysis of control or LOX silenced OV56 cells transfected with miR-508-3p inhibitor. b Transwell chamber analysis of control or LOX-overexpressing COV504 cells transfected with miR-508-3p mimic. In all bar plots, p-values are based on two-tailed Student's t-tests (*P < 0.05, **P < 0.01, ***P < 0.001)